23ANDME RELAUNCHES AS NONPROFIT WITH 100M USER TARGET

The DNA testing company's transition to nonprofit status marks a significant restructuring following financial difficulties. The 23andMe Research Institute will focus on expanding access to genetic testing and research capabilities at a broader scale. The 100 million user goal represents an aggressive expansion strategy, roughly tripling the company's current reach. As a nonprofit entity, 23andMe aims to prioritize research accessibility and data collection for scientific studies over commercial profitability. The shift in organizational structure could alter how the company monetizes genetic data and manages user privacy concerns that have historically surrounded the industry. Nonprofit status may also improve public perception and enable partnerships with research institutions. Details on funding mechanisms and operational timelines for achieving the user target remain limited.